Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
202M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
24.9M
-
Shares change
-
-661K
-
Total reported value, excl. options
-
$66.2M
-
Value change
-
-$3.92M
-
Put/Call ratio
-
0.31
-
Number of buys
-
66
-
Number of sells
-
-29
-
Price
-
$2.66
Significant Holders of ATAI Life Sciences N.V. - Common Shares (ATAI) as of Q4 2022
132 filings reported holding ATAI - ATAI Life Sciences N.V. - Common Shares as of Q4 2022.
ATAI Life Sciences N.V. - Common Shares (ATAI) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.9M shares
of 202M outstanding shares and own 12.35% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (5.66M shares), MORGAN STANLEY (2.42M shares), BlackRock Inc. (1.92M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.64M shares), Cerity Partners LLC (1.34M shares), Rubric Capital Management LP (1.32M shares), MILLENNIUM MANAGEMENT LLC (1.24M shares), TWO SIGMA INVESTMENTS, LP (975K shares), Brown University (719K shares), and Newtyn Management, LLC (600K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.